The Food and Drug Administration has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee.
Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic possibility for advanced and treatment-resistant cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback